Dashboard
Manage Tickers

DYN


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

chardan-capital-maintains-buy-on-dyne-therapeutics-raises-price-target-to-42
Chardan Capital Maintains Buy on Dyne Ther...
05/21/2024 12:15:54

Chardan Capital analyst Keay Nakae maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target from $31 ...

dyne-therapeutics-announces-300m-public-offering-of-common-stock
Dyne Therapeutics Announces $300M Public O...
05/20/2024 20:01:52

Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming...

why-is-dyne-therapeutics-stock-soaring-on-monday
Why Is Dyne Therapeutics Stock Soaring On ...
05/20/2024 19:53:38

Dyne Therapeutics reported promising Phase 1/2 trial data for DYNE-101 in myotonic dystrophy type 1 and DYNE-251 in Duchenne mu...

jefferies-maintains-buy-on-dyne-therapeutics-raises-price-target-to-42
Jefferies Maintains Buy on Dyne Therapeuti...
05/20/2024 17:32:17

Jefferies maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target from $36 to $42.

overseas-shipholding-micron-squarespace-incyte-and-other-big-stocks-moving-higher-on-monday
Overseas Shipholding, Micron, Squarespace,...
05/20/2024 15:37:53

hc-wainwright--co-maintains-buy-on-dyne-therapeutics-raises-price-target-to-48
HC Wainwright & Co. Maintains Buy on Dyne ...
05/20/2024 13:33:21

HC Wainwright & Co. analyst Andrew Fein maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target ...

Core News & Articles
Market-Moving News for May 20th
05/20/2024 12:37:59

PTCT: 27% | PTC Therapeutics Announces European Commission Returns Translarna Opinion to CHMP For Re-evaluation NKGN: 81% | NK...

dyne-therapeutics-announced-clinical-data-from-its-ongoing-phase-12-achieve-trial-of-dyne-101-in-myotonic-dystrophy-type-1-and-phase-12-deliver-trial-of-dyne-251-in-duchenne-muscular-dystrophy
Dyne Therapeutics Announced Clinical Data ...
05/20/2024 10:33:32

In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 ...

reported-sunday-dyne-therapeutics-announces-virtual-event-to-unveil-new-clinical-data-from-achieve-and-deliver-trials
Reported Sunday, Dyne Therapeutics Announc...
05/20/2024 05:48:39

 Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage muscle disease company focused on advancing innovative life-transformin...

chardan-capital-maintains-buy-on-dyne-therapeutics-maintains-31-price-target
Chardan Capital Maintains Buy on Dyne Ther...
05/06/2024 12:03:57

Chardan Capital analyst Keay Nakae maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and maintains $31 price target.

oppenheimer-reiterates-outperform-on-dyne-therapeutics-maintains-47-price-target
Oppenheimer Reiterates Outperform on Dyne ...
05/06/2024 11:55:31

Oppenheimer analyst Francois Brisebois reiterates Dyne Therapeutics (NASDAQ:DYN) with a Outperform and maintains $47 price t...

hc-wainwright--co-reiterates-buy-on-dyne-therapeutics-maintains-36-price-target
HC Wainwright & Co. Reiterates Buy on Dyne...
05/03/2024 19:46:57

HC Wainwright & Co. analyst Andrew Fein reiterates Dyne Therapeutics (NASDAQ:DYN) with a Buy and maintains $36 price tar...

morgan-stanley-initiates-coverage-on-dyne-therapeutics-with-overweight-rating-announces-price-target-of-40
Morgan Stanley Initiates Coverage On Dyne ...
04/30/2024 09:17:22

Morgan Stanley analyst Michael Ulz initiates coverage on Dyne Therapeutics (NASDAQ:DYN) with a Overweight rating and announc...

oppenheimer-reiterates-outperform-on-dyne-therapeutics-maintains-47-price-target
Oppenheimer Reiterates Outperform on Dyne ...
03/26/2024 14:07:28

Oppenheimer analyst Francois Brisebois reiterates Dyne Therapeutics (NASDAQ:DYN) with a Outperform and maintains $47 price t...

why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Landos Biopharma Shares Are Trading Hi...
03/25/2024 18:44:08

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

aehr-test-systems-reports-preliminary-results-joins-dyne-therapeutics-united-airlines-and-other-big-stocks-moving-lower-on-monday
Aehr Test Systems Reports Preliminary Resu...
03/25/2024 14:32:02

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

dyne-therapeutics-has-appointed-john-cox-as-president-chief-executive-officer-and-a-member-of-the-board-of-directors-effective-immediately-he-succeeds-joshua-brumm-who-has-chosen-to-step-down
Dyne Therapeutics Has Appointed John Cox A...
03/25/2024 11:34:39

neuromuscular-focused-avidity-biosciences-has-complete-package---analyst-predicts-stellar-142-stock-surge
Neuromuscular Focused-Avidity Biosciences ...
03/14/2024 19:29:25

Cantor Fitzgerald initiates coverage on Avidity Biosciences highlighting a robust pipeline led by del-desiran, a promising trea...

chardan-capital-maintains-buy-rating-for-dyne-therapeutics-heres-what-you-need-to-know
Chardan Capital Maintains Buy Rating for D...
03/08/2024 17:00:24

chardan-capital-maintains-buy-on-dyne-therapeutics-raises-price-target-to-31
Chardan Capital Maintains Buy on Dyne Ther...
03/08/2024 08:58:16

Chardan Capital maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target from $20 to $31.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION